H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers

Cancer Genetics and Cytogenetics

Volumn 121, Issue 1, 2000, Pages 73-77

  Przybojewska, B ^a   Jagiello, A ^b   Jalmuzna, P ^c  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^b INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

^c Provincial Centre of Diabetology and Metabolic Diseases   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER WALL; CANCER INFILTRATION; CANCER MORTALITY; FEMALE; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; PRIORITY JOURNAL;

AGED; CODON; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; URINARY BLADDER NEOPLASMS;

EID: 0033848574     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00223-5     Document Type: Article

References (12)

1. Bos J.L. ras oncogene in human cancer. a review Cancer Res. 49:1989;4682-4689.
2. Barbacid M. ras genes. Ann Rev Biochem. 56:1987;779-827.
3. Balmain A., Brown K. Oncogene activation in chemical carcinogenesis. Adv Cancer Res. 51:1988;147-182.
4. Leon J., Guerrero I., Balmain A. Differential expression of the ras gene family in mice. Mol Cell Biol. 7:1987;1535-1540.
5. International Classification of Diseases for Oncology (CD-O), Clinical Stage TNM. 1990;World Health Organization, Geneva.
6. International Histological Classification of Tumors. 1st Ed:1981;World Health Organization, Geneva.
7. Haliassos A., Liloglou M., Likourinas M., Doumas C., Ricci N., Spandidos D.A. H-ras oncogene mutations in the urine of patients with bladder tumors. description of a novel noninvasive method for the detection of neoplasia Int J Oncol. 1:1992;731-734.
8. Almoquera C., Shibata D., Forrester K., Martin J., Arnheim N., Perucho M. Most human carcinomas of the exocrine pancreas contain c-K-ras genes. Cell. 53:1988;549-554.
9. Smit V.T.H.B.M., Boot A.J.M., Smits A.M.M., Fleuren G.J., Cornelisse C.J., Bos J.L. K-ras codon 12 point mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res. 16:1988;7773-7782.
10. Husgafvel-Pursianien K., Ridanpaa M., Hackman P., Anttila S., Karialainen A., Onfelt A., Borresen A.L., Vanio H. Detection of ras gene mutations in human lung cancer. comparison of two screening assays based on the polymerase chain reaction Environ Health Perspect. 98:1992;183-185.
11. Bartram C.R., Ludwig W.D., Hiddeman W. Acute myeloid leukemia. analysis of ras gene mutations and clonality defined by polymorphic x-linked loci Leukemia. 3:1989;247-256.
12. Bell N.J., Yohn J.J., Morelli J.G., Norris D.A., Golitz L.E., Hoeffler J.P. RAS mutations in human melanoma. a marker of malignant progression J Invest Dermatol. 102:1994;285-290.